522 related articles for article (PubMed ID: 25935672)
1. Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid deposits.
Casadonte R; Kriegsmann M; Deininger SO; Amann K; Paape R; Belau E; Suckau D; Fuchser J; Beckmann J; Becker M; Kriegsmann J
Anal Bioanal Chem; 2015 Jul; 407(18):5323-31. PubMed ID: 25935672
[TBL] [Abstract][Full Text] [Related]
2. MALDI mass spectrometry imaging unravels organ and amyloid-type specific peptide signatures in pulmonary and gastrointestinal amyloidosis.
Schürmann J; Gottwald J; Rottenaicher G; Tholey A; Röcken C
Proteomics Clin Appl; 2021 Nov; 15(6):e2000079. PubMed ID: 34061454
[TBL] [Abstract][Full Text] [Related]
3. Topologies of amyloidogenic proteins in Congo red-positive sliced sections of formalin-fixed paraffin embedded tissues by MALDI-MS imaging coupled with on-tissue tryptic digestion.
Nakanishi T; Ito M; Nirasawa T; Tsuji M; Takubo T
Clin Biochem; 2013 Oct; 46(15):1595-600. PubMed ID: 23732480
[TBL] [Abstract][Full Text] [Related]
4. MALDI-mass spectrometry imaging identifies vitronectin as a common constituent of amyloid deposits.
Winter M; Tholey A; Krüger S; Schmidt H; Röcken C
J Histochem Cytochem; 2015 Oct; 63(10):772-9. PubMed ID: 26101327
[TBL] [Abstract][Full Text] [Related]
5. Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies.
Bindi G; Smith A; Oliveira G; Eccher A; Vatrano S; Alberici F; Cazzaniga G; Galimberti S; Capitoli G; Magni F; Pagni F; L'Imperio V
J Clin Pathol; 2024 May; 77(6):402-410. PubMed ID: 36813560
[TBL] [Abstract][Full Text] [Related]
6. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
Safadi S; Saad A; Quint PS; Sethi S; Leung N; Kurtin P; Nasr SH
Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
[TBL] [Abstract][Full Text] [Related]
7. Pathology and diagnosis of renal non-AL amyloidosis.
Sethi S; Theis JD
J Nephrol; 2018 Jun; 31(3):343-350. PubMed ID: 28828707
[TBL] [Abstract][Full Text] [Related]
8. MALDI Mass Spectrometry Imaging: A Novel Tool for the Identification and Classification of Amyloidosis.
Winter M; Tholey A; Kristen A; Röcken C
Proteomics; 2017 Nov; 17(22):. PubMed ID: 28994248
[TBL] [Abstract][Full Text] [Related]
9. Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis.
Sethi S; Dasari S; Amin MS; Vrana JA; Theis JD; Alexander MP; Kurtin PJ
Kidney Int; 2017 Apr; 91(4):964-971. PubMed ID: 28139293
[TBL] [Abstract][Full Text] [Related]
10. Demonstration and classification of amyloidosis in needle biopsies of the kidneys, with special reference to amyloidosis of the AA-type.
Löfberg H; Thysell H; Westman K; Larsen S; Brun C; Gruic V; Grubb A
Acta Pathol Microbiol Immunol Scand A; 1987 Nov; 95(6):357-63. PubMed ID: 3120491
[TBL] [Abstract][Full Text] [Related]
11. Pathology and Proteomics-Based Diagnosis of Localized Light-Chain Amyloidosis in Dogs and Cats.
Kadota A; Iwaide S; Miyazaki S; Mitsui I; Machida N; Murakami T
Vet Pathol; 2020 Sep; 57(5):658-665. PubMed ID: 32880234
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte chemotactic factor 2 amyloidosis cannot be reliably diagnosed by immunohistochemical staining.
Paueksakon P; Fogo AB; Sethi S
Hum Pathol; 2014 Jul; 45(7):1445-50. PubMed ID: 24792621
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of deposited peptides in amyloid lesions of AL amyloidosis by mass spectrometry].
Sugimoto T; Tasaki M; Yamashita T; Ueda M; Ando Y; Obayashi K; Okuno Y; Hata H
Rinsho Ketsueki; 2017; 58(6):589-594. PubMed ID: 28679987
[TBL] [Abstract][Full Text] [Related]
14. N-terminal peptide fragment constitutes core of amyloid deposition of serum amyloid A: An imaging mass spectrometry study.
Shintani-Domoto Y; Sugiura Y; Ogawa M; Sugiyama E; Abe H; Sakatani T; Ohashi R; Ushiku T; Fukayama M
PLoS One; 2022; 17(10):e0275993. PubMed ID: 36240260
[TBL] [Abstract][Full Text] [Related]
15. [Histopathological diagnosis of amyloidosis].
Hoshii Y
Rinsho Byori; 2006 May; 54(5):513-8. PubMed ID: 16789423
[TBL] [Abstract][Full Text] [Related]
16. Optimal conditions and the advantages of using laser microdissection and liquid chromatography tandem mass spectrometry for diagnosing renal amyloidosis.
Aoki M; Kang D; Katayama A; Kuwahara N; Nagasaka S; Endo Y; Terasaki M; Kunugi S; Terasaki Y; Shimizu A
Clin Exp Nephrol; 2018 Aug; 22(4):871-880. PubMed ID: 29372474
[TBL] [Abstract][Full Text] [Related]
17. [Classification of cardiac amyloidosis: an immunohistochemical analysis].
Li L; Duan XJ; Sun Y; Lu Y; Xu HY; Wang QZ; Wang HY
Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):105-109. PubMed ID: 29429161
[No Abstract] [Full Text] [Related]
18. [Amyloid typing from formalin-fixed paraffin-embedded tissues using LMD-LC-MS/MS system].
Tasaki M; Obayashi K; Ueda M; Ando Y
Rinsho Byori; 2014 Mar; 62(3):291-6. PubMed ID: 24800507
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical characterization of amyloid fibril precursors in renal tissue.
Wagrowska-Danilewicz M; Danilewicz M
Acta Histochem; 1996 Jul; 98(3):301-8. PubMed ID: 8863859
[TBL] [Abstract][Full Text] [Related]
20. Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing.
Satoskar AA; Efebera Y; Hasan A; Brodsky S; Nadasdy G; Dogan A; Nadasdy T
Am J Surg Pathol; 2011 Nov; 35(11):1685-90. PubMed ID: 21945954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
